nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP1B1—glaucoma	0.516	1	CbGaD
Mitoxantrone—CYP2E1—Pilocarpine—glaucoma	0.0716	0.286	CbGbCtD
Mitoxantrone—CYP2E1—Methazolamide—glaucoma	0.0484	0.193	CbGbCtD
Mitoxantrone—CYP3A4—Pilocarpine—glaucoma	0.0217	0.0866	CbGbCtD
Mitoxantrone—ABCB1—Timolol—glaucoma	0.0208	0.083	CbGbCtD
Mitoxantrone—ABCB1—Clonidine—glaucoma	0.0177	0.0706	CbGbCtD
Mitoxantrone—CYP3A4—Brinzolamide—glaucoma	0.017	0.0679	CbGbCtD
Mitoxantrone—CYP3A4—Dorzolamide—glaucoma	0.0164	0.0656	CbGbCtD
Mitoxantrone—CYP3A4—Methazolamide—glaucoma	0.0147	0.0585	CbGbCtD
Mitoxantrone—CYP3A4—Acetazolamide—glaucoma	0.0117	0.0468	CbGbCtD
Mitoxantrone—CYP3A4—Clonidine—glaucoma	0.0106	0.0423	CbGbCtD
Mitoxantrone—BTK—Treprostinil—Latanoprost—glaucoma	0.00352	0.869	CbGdCrCtD
Mitoxantrone—TOP2A—Alprenolol—Metipranolol—glaucoma	0.000312	0.077	CbGdCrCtD
Mitoxantrone—TOP2A—Alprenolol—Betaxolol—glaucoma	0.000218	0.0539	CbGdCrCtD
Mitoxantrone—Hypotension—Travoprost—glaucoma	0.000198	0.00109	CcSEcCtD
Mitoxantrone—Shock—Pilocarpine—glaucoma	0.000198	0.00109	CcSEcCtD
Mitoxantrone—Rhinitis—Betaxolol—glaucoma	0.000198	0.00109	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Pilocarpine—glaucoma	0.000197	0.00109	CcSEcCtD
Mitoxantrone—Erythema—Clonidine—glaucoma	0.000197	0.00109	CcSEcCtD
Mitoxantrone—Tachycardia—Pilocarpine—glaucoma	0.000197	0.00108	CcSEcCtD
Mitoxantrone—Dyspepsia—Brimonidine—glaucoma	0.000196	0.00108	CcSEcCtD
Mitoxantrone—Hypotension—Brinzolamide—glaucoma	0.000196	0.00108	CcSEcCtD
Mitoxantrone—Pharyngitis—Betaxolol—glaucoma	0.000196	0.00108	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Pilocarpine—glaucoma	0.000195	0.00107	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000194	0.00107	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Travoprost—glaucoma	0.000193	0.00107	CcSEcCtD
Mitoxantrone—Fatigue—Brimonidine—glaucoma	0.000192	0.00106	CcSEcCtD
Mitoxantrone—Anorexia—Pilocarpine—glaucoma	0.000192	0.00106	CcSEcCtD
Mitoxantrone—Feeling abnormal—Acetazolamide—glaucoma	0.000192	0.00106	CcSEcCtD
Mitoxantrone—Hypersensitivity—Apraclonidine—glaucoma	0.000191	0.00106	CcSEcCtD
Mitoxantrone—Paraesthesia—Dorzolamide—glaucoma	0.000191	0.00106	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000191	0.00105	CcSEcCtD
Mitoxantrone—Pain—Brimonidine—glaucoma	0.000191	0.00105	CcSEcCtD
Mitoxantrone—Dyspnoea—Dorzolamide—glaucoma	0.00019	0.00105	CcSEcCtD
Mitoxantrone—Somnolence—Dorzolamide—glaucoma	0.000189	0.00104	CcSEcCtD
Mitoxantrone—Dyspnoea—Travoprost—glaucoma	0.000189	0.00104	CcSEcCtD
Mitoxantrone—Hypotension—Pilocarpine—glaucoma	0.000188	0.00104	CcSEcCtD
Mitoxantrone—Paraesthesia—Brinzolamide—glaucoma	0.000188	0.00104	CcSEcCtD
Mitoxantrone—Dyspepsia—Dorzolamide—glaucoma	0.000188	0.00103	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Timolol—glaucoma	0.000187	0.00103	CcSEcCtD
Mitoxantrone—Dyspnoea—Brinzolamide—glaucoma	0.000187	0.00103	CcSEcCtD
Mitoxantrone—Dyspepsia—Travoprost—glaucoma	0.000187	0.00103	CcSEcCtD
Mitoxantrone—Asthenia—Apraclonidine—glaucoma	0.000186	0.00103	CcSEcCtD
Mitoxantrone—Somnolence—Brinzolamide—glaucoma	0.000186	0.00103	CcSEcCtD
Mitoxantrone—Vision blurred—Clonidine—glaucoma	0.000186	0.00102	CcSEcCtD
Mitoxantrone—Decreased appetite—Dorzolamide—glaucoma	0.000185	0.00102	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Timolol—glaucoma	0.000185	0.00102	CcSEcCtD
Mitoxantrone—Urticaria—Acetazolamide—glaucoma	0.000185	0.00102	CcSEcCtD
Mitoxantrone—Dyspepsia—Brinzolamide—glaucoma	0.000184	0.00102	CcSEcCtD
Mitoxantrone—Body temperature increased—Acetazolamide—glaucoma	0.000184	0.00101	CcSEcCtD
Mitoxantrone—Fatigue—Dorzolamide—glaucoma	0.000184	0.00101	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000183	0.00101	CcSEcCtD
Mitoxantrone—Fatigue—Travoprost—glaucoma	0.000183	0.00101	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Clonidine—glaucoma	0.000183	0.00101	CcSEcCtD
Mitoxantrone—Pain—Dorzolamide—glaucoma	0.000182	0.00101	CcSEcCtD
Mitoxantrone—Decreased appetite—Brinzolamide—glaucoma	0.000182	0.001	CcSEcCtD
Mitoxantrone—Weight decreased—Timolol—glaucoma	0.000182	0.001	CcSEcCtD
Mitoxantrone—Constipation—Travoprost—glaucoma	0.000181	0.001	CcSEcCtD
Mitoxantrone—Pain—Travoprost—glaucoma	0.000181	0.001	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Timolol—glaucoma	0.000181	0.001	CcSEcCtD
Mitoxantrone—Paraesthesia—Pilocarpine—glaucoma	0.000181	0.000997	CcSEcCtD
Mitoxantrone—Asthenia—Bimatoprost—glaucoma	0.000181	0.000997	CcSEcCtD
Mitoxantrone—Fatigue—Brinzolamide—glaucoma	0.000181	0.000996	CcSEcCtD
Mitoxantrone—Dyspnoea—Pilocarpine—glaucoma	0.00018	0.00099	CcSEcCtD
Mitoxantrone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000179	0.00373	CbGpPWpGaD
Mitoxantrone—Pain—Brinzolamide—glaucoma	0.000179	0.000988	CcSEcCtD
Mitoxantrone—Somnolence—Pilocarpine—glaucoma	0.000179	0.000987	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TXNIP—glaucoma	0.000178	0.0037	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Apraclonidine—glaucoma	0.000178	0.000981	CcSEcCtD
Mitoxantrone—Malaise—Clonidine—glaucoma	0.000178	0.00098	CcSEcCtD
Mitoxantrone—Dyspepsia—Pilocarpine—glaucoma	0.000177	0.000978	CcSEcCtD
Mitoxantrone—Chills—Betaxolol—glaucoma	0.000177	0.000975	CcSEcCtD
Mitoxantrone—Arrhythmia—Betaxolol—glaucoma	0.000176	0.000971	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dorzolamide—glaucoma	0.000176	0.000969	CcSEcCtD
Mitoxantrone—Decreased appetite—Pilocarpine—glaucoma	0.000175	0.000965	CcSEcCtD
Mitoxantrone—Feeling abnormal—Travoprost—glaucoma	0.000175	0.000964	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TBK1—glaucoma	0.000175	0.00363	CbGpPWpGaD
Mitoxantrone—Conjunctivitis—Timolol—glaucoma	0.000174	0.000961	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000174	0.000961	CcSEcCtD
Mitoxantrone—Alopecia—Betaxolol—glaucoma	0.000174	0.00096	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Travoprost—glaucoma	0.000173	0.000957	CcSEcCtD
Mitoxantrone—Feeling abnormal—Brinzolamide—glaucoma	0.000173	0.000952	CcSEcCtD
Mitoxantrone—Pain—Pilocarpine—glaucoma	0.000172	0.00095	CcSEcCtD
Mitoxantrone—Constipation—Pilocarpine—glaucoma	0.000172	0.00095	CcSEcCtD
Mitoxantrone—Cough—Clonidine—glaucoma	0.000172	0.000948	CcSEcCtD
Mitoxantrone—Sweating—Timolol—glaucoma	0.000172	0.000948	CcSEcCtD
Mitoxantrone—Erythema—Betaxolol—glaucoma	0.000172	0.000946	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00017	0.00353	CbGpPWpGaD
Mitoxantrone—Urticaria—Dorzolamide—glaucoma	0.000169	0.000934	CcSEcCtD
Mitoxantrone—Abdominal pain—Dorzolamide—glaucoma	0.000168	0.000929	CcSEcCtD
Mitoxantrone—Body temperature increased—Dorzolamide—glaucoma	0.000168	0.000929	CcSEcCtD
Mitoxantrone—Sinusitis—Timolol—glaucoma	0.000168	0.000928	CcSEcCtD
Mitoxantrone—Dysgeusia—Betaxolol—glaucoma	0.000168	0.000926	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000168	0.00349	CbGpPWpGaD
Mitoxantrone—Chest pain—Clonidine—glaucoma	0.000168	0.000925	CcSEcCtD
Mitoxantrone—Arthralgia—Clonidine—glaucoma	0.000168	0.000925	CcSEcCtD
Mitoxantrone—Abdominal pain—Travoprost—glaucoma	0.000168	0.000925	CcSEcCtD
Mitoxantrone—Agranulocytosis—Timolol—glaucoma	0.000167	0.000923	CcSEcCtD
Mitoxantrone—Anxiety—Clonidine—glaucoma	0.000167	0.000922	CcSEcCtD
Mitoxantrone—Asthenia—Acetazolamide—glaucoma	0.000167	0.00092	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000166	0.00346	CbGpPWpGaD
Mitoxantrone—Urticaria—Brinzolamide—glaucoma	0.000166	0.000918	CcSEcCtD
Mitoxantrone—Feeling abnormal—Pilocarpine—glaucoma	0.000166	0.000915	CcSEcCtD
Mitoxantrone—Discomfort—Clonidine—glaucoma	0.000166	0.000914	CcSEcCtD
Mitoxantrone—Vomiting—Apraclonidine—glaucoma	0.000165	0.000911	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000165	0.000908	CcSEcCtD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000164	0.00342	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Brimonidine—glaucoma	0.000164	0.000907	CcSEcCtD
Mitoxantrone—Bradycardia—Timolol—glaucoma	0.000164	0.000904	CcSEcCtD
Mitoxantrone—Dermatitis—Apraclonidine—glaucoma	0.000164	0.000903	CcSEcCtD
Mitoxantrone—Headache—Apraclonidine—glaucoma	0.000163	0.000898	CcSEcCtD
Mitoxantrone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000162	0.00337	CbGpPWpGaD
Mitoxantrone—Confusional state—Clonidine—glaucoma	0.000162	0.000894	CcSEcCtD
Mitoxantrone—Vision blurred—Betaxolol—glaucoma	0.000162	0.000892	CcSEcCtD
Mitoxantrone—Rhinitis—Timolol—glaucoma	0.000161	0.00089	CcSEcCtD
Mitoxantrone—Oedema—Clonidine—glaucoma	0.000161	0.000887	CcSEcCtD
Mitoxantrone—Asthenia—Brimonidine—glaucoma	0.00016	0.000883	CcSEcCtD
Mitoxantrone—Infection—Clonidine—glaucoma	0.00016	0.000881	CcSEcCtD
Mitoxantrone—Body temperature increased—Pilocarpine—glaucoma	0.000159	0.000878	CcSEcCtD
Mitoxantrone—Abdominal pain—Pilocarpine—glaucoma	0.000159	0.000878	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Betaxolol—glaucoma	0.000159	0.000878	CcSEcCtD
Mitoxantrone—Diarrhoea—Acetazolamide—glaucoma	0.000159	0.000877	CcSEcCtD
Mitoxantrone—Rash—Bimatoprost—glaucoma	0.000159	0.000876	CcSEcCtD
Mitoxantrone—Dermatitis—Bimatoprost—glaucoma	0.000159	0.000876	CcSEcCtD
Mitoxantrone—Anaemia—Betaxolol—glaucoma	0.000159	0.000874	CcSEcCtD
Mitoxantrone—Shock—Clonidine—glaucoma	0.000158	0.000873	CcSEcCtD
Mitoxantrone—Headache—Bimatoprost—glaucoma	0.000158	0.000871	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—C1QB—glaucoma	0.000158	0.00328	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000158	0.00328	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Clonidine—glaucoma	0.000157	0.000868	CcSEcCtD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000157	0.00327	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Dorzolamide—glaucoma	0.000157	0.000866	CcSEcCtD
Mitoxantrone—Tachycardia—Clonidine—glaucoma	0.000157	0.000866	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000156	0.00325	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Travoprost—glaucoma	0.000156	0.000862	CcSEcCtD
Mitoxantrone—Skin disorder—Clonidine—glaucoma	0.000156	0.000861	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Clonidine—glaucoma	0.000155	0.000857	CcSEcCtD
Mitoxantrone—Malaise—Betaxolol—glaucoma	0.000155	0.000853	CcSEcCtD
Mitoxantrone—Nausea—Apraclonidine—glaucoma	0.000154	0.000851	CcSEcCtD
Mitoxantrone—Hypersensitivity—Brinzolamide—glaucoma	0.000154	0.000851	CcSEcCtD
Mitoxantrone—Anorexia—Clonidine—glaucoma	0.000153	0.000845	CcSEcCtD
Mitoxantrone—Asthenia—Dorzolamide—glaucoma	0.000153	0.000843	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000152	0.00316	CbGpPWpGaD
Mitoxantrone—Asthenia—Travoprost—glaucoma	0.000152	0.00084	CcSEcCtD
Mitoxantrone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000151	0.00314	CbGpPWpGaD
Mitoxantrone—Asthenia—Brinzolamide—glaucoma	0.00015	0.000829	CcSEcCtD
Mitoxantrone—Hypotension—Clonidine—glaucoma	0.00015	0.000829	CcSEcCtD
Mitoxantrone—Cough—Betaxolol—glaucoma	0.00015	0.000826	CcSEcCtD
Mitoxantrone—Nausea—Bimatoprost—glaucoma	0.00015	0.000826	CcSEcCtD
Mitoxantrone—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000149	0.0031	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000149	0.00309	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Pilocarpine—glaucoma	0.000148	0.000818	CcSEcCtD
Mitoxantrone—Vomiting—Acetazolamide—glaucoma	0.000148	0.000815	CcSEcCtD
Mitoxantrone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000147	0.00305	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000146	0.000808	CcSEcCtD
Mitoxantrone—Myalgia—Betaxolol—glaucoma	0.000146	0.000805	CcSEcCtD
Mitoxantrone—Chest pain—Betaxolol—glaucoma	0.000146	0.000805	CcSEcCtD
Mitoxantrone—Arthralgia—Betaxolol—glaucoma	0.000146	0.000805	CcSEcCtD
Mitoxantrone—Diarrhoea—Dorzolamide—glaucoma	0.000146	0.000804	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—BAD—glaucoma	0.000146	0.00303	CbGpPWpGaD
Mitoxantrone—Headache—Acetazolamide—glaucoma	0.000146	0.000803	CcSEcCtD
Mitoxantrone—Anxiety—Betaxolol—glaucoma	0.000146	0.000803	CcSEcCtD
Mitoxantrone—Diarrhoea—Travoprost—glaucoma	0.000145	0.000801	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000145	0.00301	CbGpPWpGaD
Mitoxantrone—Asthenia—Pilocarpine—glaucoma	0.000144	0.000797	CcSEcCtD
Mitoxantrone—Paraesthesia—Clonidine—glaucoma	0.000144	0.000796	CcSEcCtD
Mitoxantrone—Discomfort—Betaxolol—glaucoma	0.000144	0.000796	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000144	0.003	CbGpPWpGaD
Mitoxantrone—Arrhythmia—Timolol—glaucoma	0.000144	0.000793	CcSEcCtD
Mitoxantrone—Dyspnoea—Clonidine—glaucoma	0.000143	0.000791	CcSEcCtD
Mitoxantrone—Diarrhoea—Brinzolamide—glaucoma	0.000143	0.000791	CcSEcCtD
Mitoxantrone—Somnolence—Clonidine—glaucoma	0.000143	0.000788	CcSEcCtD
Mitoxantrone—Alopecia—Timolol—glaucoma	0.000142	0.000785	CcSEcCtD
Mitoxantrone—Confusional state—Betaxolol—glaucoma	0.000141	0.000779	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TXN—glaucoma	0.000141	0.00292	CbGpPWpGaD
Mitoxantrone—Rash—Brimonidine—glaucoma	0.000141	0.000776	CcSEcCtD
Mitoxantrone—Dermatitis—Brimonidine—glaucoma	0.000141	0.000775	CcSEcCtD
Mitoxantrone—Erythema—Timolol—glaucoma	0.00014	0.000773	CcSEcCtD
Mitoxantrone—Oedema—Betaxolol—glaucoma	0.00014	0.000772	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle—RAB8A—glaucoma	0.00014	0.00291	CbGpPWpGaD
Mitoxantrone—Headache—Brimonidine—glaucoma	0.00014	0.000771	CcSEcCtD
Mitoxantrone—Decreased appetite—Clonidine—glaucoma	0.00014	0.000771	CcSEcCtD
Mitoxantrone—Infection—Betaxolol—glaucoma	0.000139	0.000767	CcSEcCtD
Mitoxantrone—Fatigue—Clonidine—glaucoma	0.000139	0.000765	CcSEcCtD
Mitoxantrone—Nausea—Acetazolamide—glaucoma	0.000138	0.000762	CcSEcCtD
Mitoxantrone—Diarrhoea—Pilocarpine—glaucoma	0.000138	0.00076	CcSEcCtD
Mitoxantrone—Shock—Betaxolol—glaucoma	0.000138	0.00076	CcSEcCtD
Mitoxantrone—Constipation—Clonidine—glaucoma	0.000137	0.000758	CcSEcCtD
Mitoxantrone—Pain—Clonidine—glaucoma	0.000137	0.000758	CcSEcCtD
Mitoxantrone—Dysgeusia—Timolol—glaucoma	0.000137	0.000757	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—BAD—glaucoma	0.000137	0.00285	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000137	0.00285	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Betaxolol—glaucoma	0.000137	0.000756	CcSEcCtD
Mitoxantrone—Tachycardia—Betaxolol—glaucoma	0.000137	0.000754	CcSEcCtD
Mitoxantrone—Skin disorder—Betaxolol—glaucoma	0.000136	0.00075	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000136	0.00282	CbGpPWpGaD
Mitoxantrone—Vomiting—Dorzolamide—glaucoma	0.000135	0.000747	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Betaxolol—glaucoma	0.000135	0.000746	CcSEcCtD
Mitoxantrone—Rash—Dorzolamide—glaucoma	0.000134	0.000741	CcSEcCtD
Mitoxantrone—Dermatitis—Dorzolamide—glaucoma	0.000134	0.00074	CcSEcCtD
Mitoxantrone—Rash—Travoprost—glaucoma	0.000134	0.000738	CcSEcCtD
Mitoxantrone—Dermatitis—Travoprost—glaucoma	0.000134	0.000737	CcSEcCtD
Mitoxantrone—Headache—Dorzolamide—glaucoma	0.000133	0.000736	CcSEcCtD
Mitoxantrone—Anorexia—Betaxolol—glaucoma	0.000133	0.000736	CcSEcCtD
Mitoxantrone—Vomiting—Brinzolamide—glaucoma	0.000133	0.000735	CcSEcCtD
Mitoxantrone—Headache—Travoprost—glaucoma	0.000133	0.000733	CcSEcCtD
Mitoxantrone—Nausea—Brimonidine—glaucoma	0.000133	0.000731	CcSEcCtD
Mitoxantrone—Feeling abnormal—Clonidine—glaucoma	0.000133	0.000731	CcSEcCtD
Mitoxantrone—Rash—Brinzolamide—glaucoma	0.000132	0.000729	CcSEcCtD
Mitoxantrone—Vision blurred—Timolol—glaucoma	0.000132	0.000728	CcSEcCtD
Mitoxantrone—Dermatitis—Brinzolamide—glaucoma	0.000132	0.000728	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Clonidine—glaucoma	0.000131	0.000725	CcSEcCtD
Mitoxantrone—Headache—Brinzolamide—glaucoma	0.000131	0.000724	CcSEcCtD
Mitoxantrone—Hypotension—Betaxolol—glaucoma	0.000131	0.000721	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000129	0.00268	CbGpPWpGaD
Mitoxantrone—Vomiting—Pilocarpine—glaucoma	0.000128	0.000706	CcSEcCtD
Mitoxantrone—Urticaria—Clonidine—glaucoma	0.000128	0.000705	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000128	0.000703	CcSEcCtD
Mitoxantrone—Body temperature increased—Clonidine—glaucoma	0.000127	0.000701	CcSEcCtD
Mitoxantrone—Abdominal pain—Clonidine—glaucoma	0.000127	0.000701	CcSEcCtD
Mitoxantrone—Rash—Pilocarpine—glaucoma	0.000127	0.0007	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—BAD—glaucoma	0.000127	0.00264	CbGpPWpGaD
Mitoxantrone—Dermatitis—Pilocarpine—glaucoma	0.000127	0.0007	CcSEcCtD
Mitoxantrone—Nausea—Dorzolamide—glaucoma	0.000127	0.000698	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000126	0.00263	CbGpPWpGaD
Mitoxantrone—Headache—Pilocarpine—glaucoma	0.000126	0.000696	CcSEcCtD
Mitoxantrone—Nausea—Travoprost—glaucoma	0.000126	0.000695	CcSEcCtD
Mitoxantrone—Paraesthesia—Betaxolol—glaucoma	0.000126	0.000693	CcSEcCtD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000126	0.00261	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000125	0.0026	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—GSTT1—glaucoma	0.000125	0.0026	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Betaxolol—glaucoma	0.000125	0.000688	CcSEcCtD
Mitoxantrone—ABCC1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000125	0.00259	CbGpPWpGaD
Mitoxantrone—Nausea—Brinzolamide—glaucoma	0.000124	0.000686	CcSEcCtD
Mitoxantrone—Dyspepsia—Betaxolol—glaucoma	0.000123	0.00068	CcSEcCtD
Mitoxantrone—BTK—Immune System—CTSA—glaucoma	0.000123	0.00256	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000123	0.00255	CbGpPWpGaD
Mitoxantrone—Cough—Timolol—glaucoma	0.000122	0.000674	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000122	0.00254	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000122	0.00254	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Betaxolol—glaucoma	0.000122	0.000671	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle—OPTN—glaucoma	0.000121	0.00252	CbGpPWpGaD
Mitoxantrone—Hypertension—Timolol—glaucoma	0.000121	0.000667	CcSEcCtD
Mitoxantrone—Fatigue—Betaxolol—glaucoma	0.000121	0.000666	CcSEcCtD
Mitoxantrone—CYP1B1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000121	0.00251	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.00012	0.0025	CbGpPWpGaD
Mitoxantrone—Pain—Betaxolol—glaucoma	0.00012	0.00066	CcSEcCtD
Mitoxantrone—Constipation—Betaxolol—glaucoma	0.00012	0.00066	CcSEcCtD
Mitoxantrone—Nausea—Pilocarpine—glaucoma	0.00012	0.00066	CcSEcCtD
Mitoxantrone—Arthralgia—Timolol—glaucoma	0.000119	0.000658	CcSEcCtD
Mitoxantrone—Chest pain—Timolol—glaucoma	0.000119	0.000658	CcSEcCtD
Mitoxantrone—Myalgia—Timolol—glaucoma	0.000119	0.000658	CcSEcCtD
Mitoxantrone—Anxiety—Timolol—glaucoma	0.000119	0.000656	CcSEcCtD
Mitoxantrone—Hypersensitivity—Clonidine—glaucoma	0.000118	0.000653	CcSEcCtD
Mitoxantrone—Discomfort—Timolol—glaucoma	0.000118	0.00065	CcSEcCtD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000118	0.00245	CbGpPWpGaD
Mitoxantrone—Asthenia—Clonidine—glaucoma	0.000115	0.000636	CcSEcCtD
Mitoxantrone—Feeling abnormal—Betaxolol—glaucoma	0.000115	0.000636	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000115	0.0024	CbGpPWpGaD
Mitoxantrone—Confusional state—Timolol—glaucoma	0.000115	0.000636	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000115	0.00238	CbGpPWpGaD
Mitoxantrone—Oedema—Timolol—glaucoma	0.000114	0.000631	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Timolol—glaucoma	0.000114	0.000631	CcSEcCtD
Mitoxantrone—Infection—Timolol—glaucoma	0.000114	0.000627	CcSEcCtD
Mitoxantrone—Shock—Timolol—glaucoma	0.000113	0.000621	CcSEcCtD
Mitoxantrone—Urticaria—Betaxolol—glaucoma	0.000111	0.000613	CcSEcCtD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000111	0.00231	CbGpPWpGaD
Mitoxantrone—Skin disorder—Timolol—glaucoma	0.000111	0.000613	CcSEcCtD
Mitoxantrone—Body temperature increased—Betaxolol—glaucoma	0.000111	0.00061	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Timolol—glaucoma	0.000111	0.00061	CcSEcCtD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00011	0.0023	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Clonidine—glaucoma	0.00011	0.000607	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.00011	0.00228	CbGpPWpGaD
Mitoxantrone—Anorexia—Timolol—glaucoma	0.000109	0.000601	CcSEcCtD
Mitoxantrone—Hypotension—Timolol—glaucoma	0.000107	0.000589	CcSEcCtD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000106	0.0022	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Timolol—glaucoma	0.000104	0.000575	CcSEcCtD
Mitoxantrone—BTK—Immune System—TXNIP—glaucoma	0.000104	0.00215	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Betaxolol—glaucoma	0.000103	0.000569	CcSEcCtD
Mitoxantrone—Paraesthesia—Timolol—glaucoma	0.000103	0.000566	CcSEcCtD
Mitoxantrone—Vomiting—Clonidine—glaucoma	0.000102	0.000564	CcSEcCtD
Mitoxantrone—Dyspnoea—Timolol—glaucoma	0.000102	0.000562	CcSEcCtD
Mitoxantrone—Somnolence—Timolol—glaucoma	0.000102	0.000561	CcSEcCtD
Mitoxantrone—BTK—Immune System—TBK1—glaucoma	0.000102	0.00211	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000102	0.00211	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—CDKN1B—glaucoma	0.000102	0.00211	CbGpPWpGaD
Mitoxantrone—Rash—Clonidine—glaucoma	0.000101	0.000559	CcSEcCtD
Mitoxantrone—Dermatitis—Clonidine—glaucoma	0.000101	0.000559	CcSEcCtD
Mitoxantrone—Headache—Clonidine—glaucoma	0.000101	0.000556	CcSEcCtD
Mitoxantrone—Dyspepsia—Timolol—glaucoma	0.000101	0.000555	CcSEcCtD
Mitoxantrone—Asthenia—Betaxolol—glaucoma	0.0001	0.000554	CcSEcCtD
Mitoxantrone—Decreased appetite—Timolol—glaucoma	9.94e-05	0.000548	CcSEcCtD
Mitoxantrone—Fatigue—Timolol—glaucoma	9.86e-05	0.000544	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.81e-05	0.00204	CbGpPWpGaD
Mitoxantrone—Pain—Timolol—glaucoma	9.78e-05	0.000539	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.78e-05	0.00203	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.62e-05	0.002	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Betaxolol—glaucoma	9.58e-05	0.000528	CcSEcCtD
Mitoxantrone—Nausea—Clonidine—glaucoma	9.55e-05	0.000527	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	9.55e-05	0.00198	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—CDKN1B—glaucoma	9.55e-05	0.00198	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Timolol—glaucoma	9.42e-05	0.00052	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—FAS—glaucoma	9.42e-05	0.00196	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Timolol—glaucoma	9.35e-05	0.000516	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.31e-05	0.00193	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—C1QB—glaucoma	9.19e-05	0.00191	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	9.11e-05	0.00189	CbGpPWpGaD
Mitoxantrone—Urticaria—Timolol—glaucoma	9.08e-05	0.000501	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism—CA5A—glaucoma	9.06e-05	0.00188	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NARFL—glaucoma	9.06e-05	0.00188	CbGpPWpGaD
Mitoxantrone—Body temperature increased—Timolol—glaucoma	9.04e-05	0.000499	CcSEcCtD
Mitoxantrone—Abdominal pain—Timolol—glaucoma	9.04e-05	0.000499	CcSEcCtD
Mitoxantrone—Vomiting—Betaxolol—glaucoma	8.9e-05	0.000491	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—CDKN1B—glaucoma	8.84e-05	0.00184	CbGpPWpGaD
Mitoxantrone—Rash—Betaxolol—glaucoma	8.83e-05	0.000487	CcSEcCtD
Mitoxantrone—Dermatitis—Betaxolol—glaucoma	8.82e-05	0.000486	CcSEcCtD
Mitoxantrone—Headache—Betaxolol—glaucoma	8.77e-05	0.000484	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism—CA5A—glaucoma	8.76e-05	0.00182	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NARFL—glaucoma	8.76e-05	0.00182	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	8.71e-05	0.00181	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	8.71e-05	0.00181	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—glaucoma	8.71e-05	0.00181	CbGpPWpGaD
Mitoxantrone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.67e-05	0.0018	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	8.53e-05	0.00177	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Timolol—glaucoma	8.43e-05	0.000465	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.39e-05	0.00174	CbGpPWpGaD
Mitoxantrone—Nausea—Betaxolol—glaucoma	8.31e-05	0.000459	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	8.26e-05	0.00172	CbGpPWpGaD
Mitoxantrone—Asthenia—Timolol—glaucoma	8.21e-05	0.000453	CcSEcCtD
Mitoxantrone—ABCC1—Disease—LRP12—glaucoma	8.2e-05	0.0017	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TXN—glaucoma	8.19e-05	0.0017	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—GSTT1—glaucoma	8.17e-05	0.0017	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	8.01e-05	0.00166	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CA5A—glaucoma	7.97e-05	0.00166	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NARFL—glaucoma	7.97e-05	0.00166	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—GSTM1—glaucoma	7.96e-05	0.00166	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—GSTM1—glaucoma	7.86e-05	0.00163	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	7.83e-05	0.00163	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Timolol—glaucoma	7.82e-05	0.000432	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	7.71e-05	0.0016	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.41e-05	0.00154	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL1A—glaucoma	7.34e-05	0.00153	CbGpPWpGaD
Mitoxantrone—Vomiting—Timolol—glaucoma	7.27e-05	0.000401	CcSEcCtD
Mitoxantrone—Rash—Timolol—glaucoma	7.21e-05	0.000398	CcSEcCtD
Mitoxantrone—Dermatitis—Timolol—glaucoma	7.2e-05	0.000397	CcSEcCtD
Mitoxantrone—Headache—Timolol—glaucoma	7.16e-05	0.000395	CcSEcCtD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.01e-05	0.00146	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	6.92e-05	0.00144	CbGpPWpGaD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.92e-05	0.00144	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	6.89e-05	0.00143	CbGpPWpGaD
Mitoxantrone—Nausea—Timolol—glaucoma	6.79e-05	0.000375	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—FAS—glaucoma	6.54e-05	0.00136	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.52e-05	0.00136	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—CYP1B1—glaucoma	6.51e-05	0.00135	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—C3—glaucoma	6.45e-05	0.00134	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	6.42e-05	0.00133	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	6.23e-05	0.00129	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.17e-05	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—C3—glaucoma	6.14e-05	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—C3—glaucoma	5.9e-05	0.00123	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—BCL2L1—glaucoma	5.88e-05	0.00122	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.84e-05	0.00121	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA5A—glaucoma	5.72e-05	0.00119	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NARFL—glaucoma	5.72e-05	0.00119	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	5.71e-05	0.00119	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.68e-05	0.00118	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	5.58e-05	0.00116	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND2—glaucoma	5.57e-05	0.00116	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	5.53e-05	0.00115	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.43e-05	0.00113	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—BAD—glaucoma	5.33e-05	0.00111	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.29e-05	0.0011	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR1OP—glaucoma	5.28e-05	0.0011	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HEYL—glaucoma	5.28e-05	0.0011	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—GSTM1—glaucoma	5.2e-05	0.00108	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	5.13e-05	0.00107	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—BAD—glaucoma	5.12e-05	0.00106	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2B—glaucoma	4.99e-05	0.00104	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.86e-05	0.00101	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.77e-05	0.000992	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CA1—glaucoma	4.42e-05	0.00092	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA5A—glaucoma	4.31e-05	0.000896	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NARFL—glaucoma	4.31e-05	0.000896	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CTSA—glaucoma	4.29e-05	0.000891	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CA1—glaucoma	4.28e-05	0.000889	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.16e-05	0.000865	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CTSA—glaucoma	4.14e-05	0.000861	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.12e-05	0.000857	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1A—glaucoma	4.07e-05	0.000846	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CA2—glaucoma	4.05e-05	0.000841	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.96e-05	0.000822	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.96e-05	0.000822	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CA2—glaucoma	3.91e-05	0.000813	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CA1—glaucoma	3.89e-05	0.000809	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.83e-05	0.000795	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.8e-05	0.000789	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.79e-05	0.000787	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.77e-05	0.000784	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CTSA—glaucoma	3.77e-05	0.000784	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.74e-05	0.000778	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CDKN1B—glaucoma	3.71e-05	0.000771	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.67e-05	0.000763	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—C3—glaucoma	3.58e-05	0.000743	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDKN1B—glaucoma	3.56e-05	0.00074	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CA2—glaucoma	3.56e-05	0.00074	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.53e-05	0.000733	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—glaucoma	3.52e-05	0.000732	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2L1—glaucoma	3.42e-05	0.000711	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HDAC9—glaucoma	3.3e-05	0.000685	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.24e-05	0.000674	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.23e-05	0.000671	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	3.19e-05	0.000664	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BAD—glaucoma	3.1e-05	0.000645	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.02e-05	0.000627	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.98e-05	0.000619	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—glaucoma	2.86e-05	0.000593	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TXN—glaucoma	2.85e-05	0.000593	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.83e-05	0.000588	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA1—glaucoma	2.8e-05	0.000581	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—glaucoma	2.78e-05	0.000577	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.76e-05	0.000574	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TXN—glaucoma	2.76e-05	0.000573	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CTSA—glaucoma	2.71e-05	0.000563	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA5A—glaucoma	2.66e-05	0.000552	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NARFL—glaucoma	2.66e-05	0.000552	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.6e-05	0.000541	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.58e-05	0.000536	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.58e-05	0.000536	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA2—glaucoma	2.56e-05	0.000531	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1B—glaucoma	2.53e-05	0.000525	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.52e-05	0.000523	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TXN—glaucoma	2.51e-05	0.000521	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.49e-05	0.000518	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.41e-05	0.000502	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.38e-05	0.000495	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTT1—glaucoma	2.21e-05	0.000459	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1B—glaucoma	2.16e-05	0.000449	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTT1—glaucoma	2.14e-05	0.000444	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA1—glaucoma	2.11e-05	0.000437	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CTSA—glaucoma	2.04e-05	0.000424	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.03e-05	0.000422	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTT1—glaucoma	1.95e-05	0.000404	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA2—glaucoma	1.93e-05	0.0004	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.92e-05	0.0004	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TXN—glaucoma	1.8e-05	0.000374	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.78e-05	0.00037	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN2B—glaucoma	1.77e-05	0.000368	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCA1—glaucoma	1.76e-05	0.000366	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000366	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.72e-05	0.000358	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCA1—glaucoma	1.7e-05	0.000354	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.6e-05	0.000332	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—glaucoma	1.59e-05	0.00033	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1B1—glaucoma	1.55e-05	0.000322	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCA1—glaucoma	1.55e-05	0.000322	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—glaucoma	1.49e-05	0.000309	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—glaucoma	1.41e-05	0.000293	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTT1—glaucoma	1.4e-05	0.00029	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—glaucoma	1.38e-05	0.000288	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.37e-05	0.000285	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CAV1—glaucoma	1.37e-05	0.000285	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—glaucoma	1.36e-05	0.000283	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TXN—glaucoma	1.36e-05	0.000282	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA1—glaucoma	1.3e-05	0.00027	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BAD—glaucoma	1.29e-05	0.000268	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CTSA—glaucoma	1.26e-05	0.000261	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—glaucoma	1.24e-05	0.000259	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—glaucoma	1.24e-05	0.000258	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.21e-05	0.000251	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—glaucoma	1.2e-05	0.00025	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA2—glaucoma	1.19e-05	0.000247	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—glaucoma	1.16e-05	0.000241	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAV1—glaucoma	1.15e-05	0.000239	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—glaucoma	1.12e-05	0.000233	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1B1—glaucoma	1.11e-05	0.000231	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCA1—glaucoma	1.11e-05	0.000231	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAV1—glaucoma	1.11e-05	0.000231	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—glaucoma	1.1e-05	0.000228	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—glaucoma	1.05e-05	0.000219	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—glaucoma	1.04e-05	0.000215	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—glaucoma	1.02e-05	0.000212	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAV1—glaucoma	1.01e-05	0.00021	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—glaucoma	9.48e-06	0.000197	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—glaucoma	8.98e-06	0.000187	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—glaucoma	8.9e-06	0.000185	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—glaucoma	8.68e-06	0.00018	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—glaucoma	8.4e-06	0.000174	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCA1—glaucoma	8.38e-06	0.000174	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1B1—glaucoma	8.38e-06	0.000174	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TXN—glaucoma	8.36e-06	0.000174	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—glaucoma	7.94e-06	0.000165	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—glaucoma	7.86e-06	0.000163	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—glaucoma	7.68e-06	0.00016	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—glaucoma	7.64e-06	0.000159	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—glaucoma	7.32e-06	0.000152	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAV1—glaucoma	7.25e-06	0.000151	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—glaucoma	6.99e-06	0.000145	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—glaucoma	6.7e-06	0.000139	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—glaucoma	6.48e-06	0.000135	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—glaucoma	5.92e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—glaucoma	5.51e-06	0.000115	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—glaucoma	5.48e-06	0.000114	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAV1—glaucoma	5.46e-06	0.000113	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1B1—glaucoma	5.16e-06	0.000107	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCA1—glaucoma	5.16e-06	0.000107	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—glaucoma	5.02e-06	0.000104	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—glaucoma	4.13e-06	8.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—glaucoma	4.13e-06	8.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—glaucoma	3.78e-06	7.85e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—glaucoma	3.65e-06	7.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—glaucoma	3.4e-06	7.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAV1—glaucoma	3.36e-06	6.99e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—glaucoma	2.54e-06	5.29e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—glaucoma	2.33e-06	4.84e-05	CbGpPWpGaD
